Patrick Daly

DocwireNews

In a meta-analysis, published in the&nbsp;Journal of Medical Economics, researchers compared the efficacy of <a href="https://medlineplus.gov/druginfo/meds/a622010.html">tezepelumab</a> and other approved biologic therapies in patients aged 12 years or more with severe uncontrolled asthma. The study&rsquo;s lead author, Andrew Menzies-Gow, and colleagues ultimately felt their evidence supported the use of tezepelumab in this population, regardless of phenotype or baseline patient characteristics.The authors&rsquo; systematic literature review enrolled 16 studies across for indirect treatment comparisons (ITCs) via a network meta-analysis (NMA) or a simulated treatment comparison (STC) approach. The primary end points of the meta-analysis were annualized asthma exacerbation rate (AAER) and AAER of events leading to hospitalization or emergency department visit.<h3>Tezepelumab Demonstrated Potential Benefits Versus Other Biologics</h3>Biologics agents in the review included <a href="https://www.docwirenews.com/latest-pulmonology-news/asthma/tezepelumab-halves-exacerbation-rates-in-severe-uncontrolled-asthma/">tezepelumab</a>, dupilumab, benralizumab, mepolizumab, reslizumab, and omalizumab. The authors reported that all of the therapies exhibited similar efficacy with no significant differences in risk ratios for the primary outcomes; However, they noted that tezepelumab was correlated with lower trendings AAERs overall, and was the most effect biologic for the exacerbation outcomes.The authors acknowledged a degree of heterogeneity between the included trials&rsquo; enrollment criteria and clinically important characteristics; Nonetheless, they felt the potential impact of this limitation was low.Ultimately, the authors supported the broad efficacy of tezepelumab in patients with severe uncontrolled asthma, and hypothesized its potential advantages versus other biologics could be &ldquo;because TSLP, the target of tezepelumab, is positioned higher up the inflammatory cascade than other targets, which may lead to broader effects on airway inflammation and structural airway changes.Find More Recent Studies and Reviews on the <a href="https://www.docwirenews.com/asthma-resource-center/">Asthma Resource Center</a>

Bradley Marder, MD

Joel M. Topf, MD, FACP

Gout Studies: Transplant Waitlisting and Bone Erosion

NKF Spring Clinical Meetings 2025

Jayme Locke, MD, MPH

The Promise of Xenotransplantation

Leah Lawrence

Real-World Data Backs Invasive DFS as Surrogate Endpoint for OS in EBC

HR Breast Cancer

Latest News

Comparing Tezepelumab to Other Biologics in Severe Asthma Treatment

Asthma

In a meta-analysis, published in the Journal of Medical Economics, researchers compared the efficacy of tezepelumab and other approved biologic therapies in patients aged 12 ...

About Us

Editorial Policy

Advertising

Contact Us

eNewsletters

Contribute

Career Center

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

HER2 Breast Cancer

Triple-Negative Breast Cancer

Genetics & Breast Cancer

Breast Cancers Today

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Breast Cancer

Gynecologic Cancer

Head and Neck Cancer

Skin Cancer

Oncology

Sleep

Urology

Diabetes

Ophthalmology

— Demodex Blepharitis

Neurology

Rheumatology

Gastroenterology

Pulmonology

Infectious Diseases

— HIV

Health and Wellness

Lupus

Future of Medicine

Orthopedics

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

Rheumatology Rounds With Dr. Maheswaranathan

Partners

Expert Interviews

Subscribe